Physician profile
Jonathan M Spanier
NPI 1154351690
$928.30
in general payments reported to CMS, 2019-2025
18 companies · $185 in 2025
The $185 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $233 · 2020: $67.46 · 2021: $168 · 2022: $68.00 · 2023: $91.41 · 2024: $115 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $391.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $181.36 | 2019-2025 | Dyanavel Xr |
| Cranial Technologies, INC | $135.98 | 2019-2024 | Doc Band |
| Glaxosmithkline, LLC. | $120.01 | 2019-2025 | Bexsero, Pediarix |
| Ironshore Pharmaceuticals INC. | $78.35 | 2019 | |
| Pfizer INC. | $68.83 | 2020-2025 | |
| Biomarin Pharmaceutical INC. | $56.20 | 2024-2025 | Voxzogo 1.2mg |
| Seqirus USA INC | $44.04 | 2021-2025 | Flucelvax |
| Takeda Pharmaceuticals U.S.A., INC. | $35.51 | 2021-2022 | |
| Sobi, INC | $33.74 | 2019 | |
| Abbvie INC. | $26.92 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $21.43 | 2025 | |
| Sanofi Pasteur INC. | $21.27 | 2024 | |
| Supernus Pharmaceuticals, INC. | $21.08 | 2021 | |
| Alexion Pharmaceuticals, INC. | $20.18 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $18.97 | 2025 | Bylvay |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $16.75 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.91 | 2025 | Zoryve |
| Ars Pharmaceuticals Operations, INC. | $13.77 | 2025 | Neffy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Spanier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.